10
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Action of A Mycotoxin (Diacetoxyscirpenol) on the Immune Response of the Mouse-Interaction with An Immunomodulator (Om-89)

, &
Pages 311-325 | Published online: 28 Sep 2008

References

  • Bamburg J. R., Strong F. M. 12, 13 époxytrichothecenes. “Microbial toxins”, S. Kadis, A. Ciegler, S. J. Ajl. Academic Press Inc., New-York 1971; Vol. VII: 207–292
  • Bamburg J. R. Biological and biochemical actions of trichothecene myxotoxins. “Progress in molecular and subcellular biology”. Springer-Verlag, Berlin 1983; Vol. 8: 81–110
  • Bauer J., Bollwahn W., Gareis M., Gedek B., Heinritzi K. Kinetic profiles of diacetoxyscirpenol and two of its metabolites in blood serum of pigs. Appl. Environ. Microbiol. 1985; 49: 842–845
  • Boonchuvit B., Hamilton P. B., Burmeister H. R. Interaction of t-2 toxin with Salmonella infections of chicken. Poultry Science 1975; 54: 1693–1696
  • Cunnigham A. J., Szenber A. further improvements in the plaque technique for detecting single antibody formin cells. Immunology 1968; 14: 599
  • Descotes J., Evreuxcl J. Immunomodulating agents. “Meyler's side effects of drugs”. Elseiver Sciences Publishers, Duke, ED 1984; 711–714
  • Fromentin H., Salazar-Mejicanos S., Mariat F. Pathogenicity of Candida albicans for normal mice and mice treated by the mycotoxin diacétoxyscirpénol. Anal. Microbiol. 1980; 131: 39–46
  • Hernandez F., Cannon M. Inhibition of protein synthesis in Saccharomyces cerevisial by the 12, 13 epoxytrichothecenes trichodermol, diacetoxyscirpenil and verrucarin. A reversibility of the effects. J. Antibiot. 1982; 35(7)875–881, Tokyo
  • Kanai K., Kondo E. Decreased resistance to mycobacterial infection in mice fed a trichothecene compount (t-2 toxin). Japan J. Med. Sci. Biol. 1984; 37: 97–104
  • Liao, Grollman A. P., Horwitz S. B. Mechanism of action of the 12, 13 epoxytrichothecene, an-guidine, an inhibitor of protein synthesis. Biochem. Biophys. Acta. 1976; 454: 273–284
  • Magyar T., Soltensky J., Kontrohr T., Lendvat N., Rethy L. A., Geresi M., Hegedus L., Rethy L. Trials to define the degree of the adjuvanting activity of immunomodulants of microbiological origin. Ann. Immunol. Hung. 1983; 23: 197–203
  • Makioka A., Kobayashi A. Immunomodulation by tetrahymena pyroformis; microbiol. Immunol. 1984; 28(4)503–507
  • Otakawa M. Trichothecenes: chemical, biological and toxicological aspects. “Immunological disorders”, Kondanska, Elseiver, Tokyo, Amsterdam 1983; 163–170
  • Rosenstein Y., Lafarge-Frayssinet C., Lespinats G., Loisillier F., Lafont P., Frayssinet C. Immunosuppressive activity of Fusarim toxins. Effects on antibody synthesis and skin grafts of crude extracts, t-2 toxin and diacetoxyscirpenol. Immunology 1979; 36: 111–117
  • Saito M., Ohtsubo K. Trichothecene toxins of Fusarim species. “Mycotoxins”. I.F.H. Purshase
  • Satoshi M. Mechanism of inhibition of protein synthesis initiation by diacetoxyscirpenol and Fusarenone X in the reticulocyte lysate system. Biochem. Bioph. Acta. 1975; 383: 207–214
  • Thong Y. H. Imnunomodulation by antimicrobial drugs. Medical hypotheses 1982; 8: 361–370
  • Ueno Y., Hosoya M., Ishikawa Y. Inhibitory effects of mycotoxins on the protein synthesis in rabbit reticulocytes. J. Biochem., Tokyo 1969; 66: 419–422
  • Ueno Y., Ishikawa Y., Saito-Amakai K., Tsunoda H. Environmental factors influencing the production of Fusarenone X, a cytotoxic mycotoxin of Fusarium nivale Fn 2B. Chem. Pharm. Bull. 1970; 8: 304–312
  • Ueno Y., Sato N., Ishii K., Sakai K., Enomoto M. Toxicological approaches to the metabolites of Fusaria V. Neosolaniol, t-2 toxin and butenolide, toxic metabolites of Fusarium sporotrichioides NRRL 3287. Japan J. Exp. Med. 1972; 42: 461–472
  • Ueno Y., Sato N., Ishii K., Sakai K., Tsunoda H., Enomoto M. Biological and chemical detection of trichothecene mycotoxins of Fusarium species. Appl. Microbiol. 1973; 25(4)699–704
  • Ueno Y., Ueno I., Iitoi Y., Tsunoda H., Enomoto M., Ohtsubo K. Toxicological approaches to the metabolites of Fusaria III. acute toxicity of fusarenone X. Jap. J. Exptl. Med. 1971; 41: 521–539

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.